Long-term efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: week 104 results from the SUNSHINE and SUNRISE extension trial
The primary endpoint of this trial was not met. HiSCR was maintained in many patients at the time of LOR. The safety of secukinumab was consistent with the previously characterized safety profile in the core trials.
Authors
- Francesca Gasperoni (ORCID: https://orcid.org/0000-0002-1713-9477)
- Z. Reguiaï (ORCID: https://orcid.org/0000-0002-9177-8525)
- Evangelos J. Giamarellos‐Bourboulis (ORCID: https://orcid.org/0000-0003-4713-3911)
- Lorenz Uhlmann (ORCID: https://orcid.org/0000-0001-8668-069X)
- Bertrand Paguet
- Ivette Alarcón (ORCID: https://orcid.org/0000-0002-6738-2651)
- Alice Bendix Gottlieb (ORCID: https://orcid.org/0000-0002-2927-8618)
- Alexa B. Kimball (ORCID: https://orcid.org/0000-0001-9405-0479)
- Falk G. Bechara (ORCID: https://orcid.org/0000-0003-0418-521X)
- Afsáneh Alavi (ORCID: https://orcid.org/0000-0003-1171-4917)
- Gregor B. E. Jemec (ORCID: https://orcid.org/0000-0002-0712-2540)
- Amita Bansal (ORCID: https://orcid.org/0000-0001-8716-9922)
- A. Villani (ORCID: https://orcid.org/0000-0002-3067-807X)
- Hichem Zouater (ORCID: https://orcid.org/0000-0002-6572-8946)
- Ruvie Martin
- Shoba Ravichandran
- Aysha Badat
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Novartis (Switzerland) (CH)
- Beth Israel Deaconess Medical Center (US)
- Mayo Clinic (US)
- Harvard University (US)
- National and Kapodistrian University of Athens (GR)
- University Hospitals of the Ruhr-University of Bochum (DE)
- Chris Hani Baragwanath Hospital (ZA)
- Zealand University Hospital (DK)
- Hospices Civils de Lyon (FR)
- Novartis (United States) (US)
- Mayo Clinic in Arizona (US)
- Polyclinique de Franche Comté (FR)
- Tris Pharma (United States) (US)
- Ruhr University Bochum (DE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1093/bjd/ljae469
- Citations
- 8
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.28